The Jiedu Tongluo Baoshen Formula similarly inhibits the PI3K/Akt/mTOR signaling pathway, enhancing podocyte autophagy and reducing podocyte injury, thus offering an effective treatment for DKD (Jin et al., 2022). This evidence concerns the gene MTOR and diabetic kidney disease.